Hiroshi Yamagami

Dr. Hiroshi Yamagami

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Stroke
Verified
Journal Article
Open access
PDF file
SKShunsuke Kimura
Shunsuke Kimura
KTKazunori Toyoda
Kazunori Toyoda
SYSohei Yoshimura
Sohei Yoshimura
KMKazuo Minematsu
Kazuo Minematsu
MYMasahiro Yasaka
Masahiro Yasaka
MKMasatoshi Koga
Masatoshi Koga
Background: The “1-3-6-12-day rule” for starting direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation after acute ischemic stroke or transient ischemic attack recommends timings that may be later than used in clinical practice. We investigated more practical optimal timing of DOAC initiation according to stroke severity. Methods: The combined data of prospective registries in Japan, Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-nonvalvular atrial fibrillation (September 2011 to March 2014) and RELAXED (February 2014 to April 2016) were used. Patients were divided into transient ischemic attack and 3 stroke subgroups by the National Institutes of Health Stroke Scale score: mild (0–7), moderate (8–15), and severe (≥16). The early treatment group was defined as patients starting DOACs earlier than the median initiation day in each subgroup. Outcomes included a composite of recurrent stroke or systemic embolism, ischemic stroke, and severe bleeding within 90 days. Six European prospective registries were used for validation. Results: In the 1797 derivation cohort patients, DOACs were started at median 2 days after transient ischemic attack and 3, 4, and 5 days after mild, moderate, and severe strokes, respectively. Stroke or systemic embolism was less common in Early Group (n=785)—initiating DOACS within 1, 2, 3, and 4 days, respectively—than Late Group (n=1012) (1.9% versus 3.9%; adjusted hazard ratio, 0.50 [95% CI, 0.27–0.89]), as was ischemic stroke (1.7% versus 3.2%, 0.54 [0.27–0.999]). Major bleeding was similarly common in the 2 groups (0.8% versus 1.0%). On validation, both ischemic stroke (2.4% versus 2.2%) and intracranial hemorrhage (0.2% versus 0.6%) were similarly common in Early (n=547) and Late (n=1483) Groups defined using derivation data. Conclusions: In Japanese and European populations, early DOAC initiation within 1, 2, 3, or 4 days according to stroke severity seemed to be feasible to decrease the risk of recurrent stroke or systemic embolism and no increase in major bleeding. These findings support ongoing randomized trials to better establish the optimal timing of DOAC initiation.

1 January 2021 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
PDF file
HYHiroshi Yamagami
Hiroshi Yamagami
MHMikito Hayakawa
Mikito Hayakawa
MIManabu Inoue
Manabu Inoue
KIKoji Iihara
Koji Iihara
KOKuniaki Ogasawara
Kuniaki Ogasawara
JCJSS/JNS/JSNET Joint Guideline Authoring Committee
JSS/JNS/JSNET Joint Guideline Authoring Committee
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 September 2017 in Stroke
Verified
Journal Article
Closed access
PDF file
JTJunji Takasugi
Junji Takasugi
HYHiroshi Yamagami
Hiroshi Yamagami
TNTeruo Noguchi
Teruo Noguchi
YMYoshiaki Morita
Yoshiaki Morita
TTTomotaka Tanaka
Tomotaka Tanaka
KNKazuyuki Nagatsuka
Kazuyuki Nagatsuka
Background and Purpose—: We aimed to use contrast-enhanced cardiac magnetic resonance (CE-CMR) imaging to elucidate the prevalence of left ventricular (LV) thrombus in patients suspected of embolic stroke of undetermined source (ESUS) with previous myocardial infarction or LV dysfunction (LV ejection fraction [LVEF] <50%). Methods—: We prospectively investigated 797 consecutive patients who presented to our hospital with acute ischemic stroke between 2014 and 2015. Patients with myocardial infarction or LVEF<50% underwent CE-CMR imaging. ESUS was diagnosed according to proposal criteria based on transthoracic echocardiography findings. Results—: The prevalence of ESUS was 22% (178 of 797) on initial diagnosis. Among 60 patients with myocardial infarction or LVEF<50%, the stroke subtypes were as follows: small artery disease, 17% (10 of 60); large artery atherosclerosis, 5% (3 of 60); cardioembolic stroke, 49% (29 of 60); ESUS, 23% (14 of 60); and undetermined causes other than ESUS, 6% (4 of 60). Of 60 patients examined via CE-CMR, LV thrombus was confirmed in 12 patients, whereas only 1 had been detected on transthoracic echocardiography ( P =0.04). Importantly, 29% (4 of 14) of patients with ESUS had LV thrombus. A prediction model based on CE-CMR findings showed higher performance in LV thrombus detection, permitting a net improvement of 0.46 (95% confidence interval, 0.08–0.82; P =0.016) in cardioembolic stroke reclassification. Compared with patients without LV thrombus, those with LV thrombus had lower LVEF (median: 26% versus 40%; P =0.003). Notably, 42% (5 of 12) of patients with LV thrombus had LVEF≥30%. Conclusions—: When ESUS-suspected patients have myocardial infarction or LV dysfunction, CE-CMR may help improve detection of cardioembolic stroke and provide relevant information for anticoagulation therapy. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT02251665.

15 January 2012 in Journal of the Physical Society of Japan
Verified
Journal Article
Closed access
PDF file
SFShin-Ichi Fujimori
Shin-Ichi Fujimori
TOTakuo Ohkochi
Takuo Ohkochi
IKIkuto Kawasaki
Ikuto Kawasaki
AYAkira Yasui
Akira Yasui
YTYukiharu Takeda
Yukiharu Takeda
YŌYoshichika Ōnuki
Yoshichika Ōnuki
High-energy-resolution core-level and valence-band photoelectron spectroscopic studies were performed for the heavy fermion uranium compounds UGe 2 , UCoGe, URhGe, URu 2 Si 2 , UNi 2 Al 3 , UPd 2 Al 3 , and UPt 3 as well as typical localized and itinerant uranium compounds to understand the relationship between the uranium valence state and their core-level spectral line shapes. In addition to the main line and high-binding energy satellite structure recognized in the core-level spectra of uranium compounds, a shoulder structure on the lower binding energy side of the main lines of localized and nearly localized uranium compounds was also found. The spectral line shapes show a systematic variation depending on the U 5 f electronic structure. The core-level spectra of UGe 2 , UCoGe, URhGe, URu 2 Si 2 , and UNi 2 Al 3 are rather similar to those of itinerant compounds, suggesting that U 5 f electrons in these compounds are well hybridized with ligand states. On the other hand, the core-level spectra of UPd 2 Al 3 and UPt 3 show considerably different spectral line shapes from those of the itinerant compounds, suggesting that U 5 f electrons in UPd 2 Al 3 and UPt 3 are less hybridized with ligand states, leading to the correlated nature of U 5 f electrons in these compounds. The dominant final state characters in their core-level spectra suggest that the numbers of 5 f electrons in UGe 2 , UCoGe, URhGe, URu 2 Si 2 , UNi 2 Al 3 , and UPd 2 Al 3 are close to but less than three, while that of UPt 3 is close to two rather than to three.

1 April 2017 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
YSYuri Sugiura
Yuri Sugiura
HYHiroshi Yamagami
Hiroshi Yamagami
NSNobuyuki Sakai
Nobuyuki Sakai
SYShinichi Yoshimura
Shinichi Yoshimura

24 January 2023 in Neurology
Verified
Journal Article
Closed access
PDF file
Thanh N NguyenThanh N Nguyen
Thanh N Nguyen
MQMuhammad M. Qureshi
Muhammad M. Qureshi
PKPiers Klein
Piers Klein
HYHiroshi Yamagami
Hiroshi Yamagami
RMRobert Mikulik
Robert Mikulik
TRthe SVIN COVID-19 Global Stroke Registry
the SVIN COVID-19 Global Stroke Registry
Background and Objectives Declines in stroke admission, IV thrombolysis (IVT), and mechanical thrombectomy volumes were reported during the first wave of the COVID-19 pandemic. There is a paucity of data on the longer-term effect of the pandemic on stroke volumes over the course of a year and through the second wave of the pandemic. We sought to measure the effect of the COVID-19 pandemic on the volumes of stroke admissions, intracranial hemorrhage (ICH), IVT, and mechanical thrombectomy over a 1-year period at the onset of the pandemic (March 1, 2020, to February 28, 2021) compared with the immediately preceding year (March 1, 2019, to February 29, 2020). Methods We conducted a longitudinal retrospective study across 6 continents, 56 countries, and 275 stroke centers. We collected volume data for COVID-19 admissions and 4 stroke metrics: ischemic stroke admissions, ICH admissions, IVT treatments, and mechanical thrombectomy procedures. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 148,895 stroke admissions in the 1 year immediately before compared with 138,453 admissions during the 1-year pandemic, representing a 7% decline (95% CI [95% CI 7.1–6.9]; p < 0.0001). ICH volumes declined from 29,585 to 28,156 (4.8% [5.1–4.6]; p < 0.0001) and IVT volume from 24,584 to 23,077 (6.1% [6.4–5.8]; p < 0.0001). Larger declines were observed at high-volume compared with low-volume centers (all p < 0.0001). There was no significant change in mechanical thrombectomy volumes (0.7% [0.6–0.9]; p = 0.49). Stroke was diagnosed in 1.3% [1.31–1.38] of 406,792 COVID-19 hospitalizations. SARS-CoV-2 infection was present in 2.9% ([2.82–2.97], 5,656/195,539) of all stroke hospitalizations. Discussion There was a global decline and shift to lower-volume centers of stroke admission volumes, ICH volumes, and IVT volumes during the 1st year of the COVID-19 pandemic compared with the prior year. Mechanical thrombectomy volumes were preserved. These results suggest preservation in the stroke care of higher severity of disease through the first pandemic year. Trial Registration Information This study is registered under NCT04934020.